Drs. Steve Xu and William Ju discuss how dermatologists can fuel success by breaking down patient problems to find innovative solutions.
Introducing a new column called “Innovation” from the co-founders of Advancing Innovation in Dermatology Accelerator Fund. In the first installment of this series, Drs. Steve Xu and William Ju address the importance of innovation in dermatology.
LEO Pharma and its Boston-based R&D innovation unit LEO Science & Tech Hub, and Advancing Innovation in Dermatology (AID) announced today that LEO and AID will each contribute $500,000 into the recently created Advancing Innovation in Dermatology Accelerator Fund.
The accelerator will provide economic and intellectual capital to further a discovery’s potential for commercialization
Revolutionary advancements continue to be made in the field of dermatology. At LEO Pharma, we are gaining exposure to many of these innovations on a daily basis.
For nearly 50 years, the European Society for Dermatological Research (ESDR) has made great efforts in supporting its members to advance research in cutaneous biology and related subjects, thereby improving our ability to maintain or restore normal structure and function of skin, i.e. skin health
Welcome to the sixth installment of Benchside Dispatch, a series of interviews with top researchers in the field of dermatology intended to highlight important advances in the care of medical skin disorders.
Welcome to the fifth installment of Benchside Dispatches. In this installment, Angela Christiano, PhD, discusses epider molysis bullosa (EB). Dr. Christiano is the Richard and Mildred Rhodebeck Professor of Dermatology and Professor of Genetics & Development and Director, Basic Science Research Group of Dermatology at Columbia University College of Physicians & Surgeons.